Cytiva and Culture Biosciences Partner to Deliver Seamless Scale-Up with Stratyx 250 Bioreactor

  Cytiva has deepened its partnership with Culture Biosciences, introducing the Stratyx 250 process development bioreactor. Speaking to BioPharma Boa...

August 18, 2025 | Monday | News
OmniAb CEO Matt Foehr Highlights Robust Partner Growth and Innovation Momentum in Q2 2025 Results

OmniAb, Inc. reported financial results for the three and six months ended June 30, 2025, and provided operating and partner program updates. “Our...

August 07, 2025 | Thursday | Company results
Thierry Bernard Leads QIAGEN to Strong Q2 2025 Results with $534 Million in Sales and Upgraded Outlook

Q2 2025 results: Net sales of $534 million (+7% actual rates); adjusted diluted EPS of $0.60 Net sales +6% CER (constant exchange rates) above out...

August 06, 2025 | Wednesday | Company results
Cytiva’s Ludovic Brellier on Future-Ready Biomanufacturing with the ÄKTA readyflux TFF System 500

As advanced modalities like mRNA and viral vectors reshape the biomanufacturing landscape, Cytiva is scaling innovation to meet evolving demands. In this e...

August 05, 2025 | Tuesday | Interaction
HKBU-Led Team Unveils Magnetically Guided Nanorobot to Combat Pollution, Bacteria, and Biofilms

A collaborative research team led by Hong Kong Baptist University (HKBU) has developed a multifunctional nanorobot equipped with silver and gold nanorods...

August 04, 2025 | Monday | News
Christophe Beck Leads Ecolab to Double-Digit Earnings Growth with Strong Q2 Performance

Christophe Beck, Ecolab’s chairman and chief executive officer, said, “The Ecolab team executed very well to deliver another strong quarter o...

July 30, 2025 | Wednesday | Company results
Marc N. Casper Credits Agile Execution and Trusted Partnerships as Thermo Fisher Delivers Resilient Q2 2025 Results

“Our exceptional team continues to execute at a high level, enabling customer success while navigating the macroenvironment. The agility of our o...

July 24, 2025 | Thursday | Company results
New CEO Dr Michael Grosse Charts Confident Course for Sartorius, Backed by Pharma-Focused Expansion

Group sales revenue up 6.1 percent in the first six months As expected, continued positive trend in recurring business with consumables Bioproce...

July 22, 2025 | Tuesday | Company results
Rare Voices, Real Impact as Alexion Humanises Rare Disease Care

In this BioPharma Boardroom discussion, we speak with Christophe Hotermans, Head of Global Medical Affairs at Alexion, AstraZeneca Rare Disease. From the e...

July 21, 2025 | Monday | Interaction
Andrew Wyatt of Sapio Sciences on How LIMS is Redefining Data Management and Driving Unprecedented Efficiency in Modern Research and Clinical Labs

  Every aspect of science and research is based on data, and across the globe, labs are producing more data than the average person can even comprehe...

July 01, 2025 | Tuesday | Expert Opinion
Cytiva’s “In-Region, For-Region” Strategy Powers $1.6 Billion Global Biomanufacturing Expansion

Since 2019, Cytiva has committed over $1.6 billion to expand its global manufacturing capacity. In this exclusive conversation with BioPharma BoardRoom, Pi...

July 01, 2025 | Tuesday | Interview
Integrated CMC workflows for current and next-generation ADCs

ADCs are no longer a niche modality. To date, there are over a dozen approved ADCs on the market, and more than 500 programs are in clinical development, d...

June 16, 2025 | Monday | Expert Opinion
Forging the Future of Biomanufacturing: How VVMF and Cytiva Are Elevating Australia’s Global Role

As the world recalibrates its life sciences infrastructure post-pandemic, Australia is stepping up as a regional powerhouse in biomanufacturing—espec...

June 05, 2025 | Thursday | Interaction
The Challenge of Modern Drug Discovery

Enter Generative AI: A Paradigm Shift Today, generative AI is changing this equation. Unlike traditional AI that analyzes existing data, generative AI can...

June 03, 2025 | Tuesday | Expert Opinion

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close